Latest / Investment Research Radio
Nutromics With CEO Peter Vranes
Investment Research Radio: Nutromics — Precision Antibiotic Dosing and the Future of Wearable Biosensing
In this episode of Investment Research Radio, we explore Nutromics and its innovative wearable microneedle technology designed to transform precision medicine and continuous molecular monitoring.
Nutromics' first product focuses on vancomycin, a powerful antibiotic widely used in hospitals to treat serious infections, including MRSA and sepsis. Because vancomycin has a narrow therapeutic window, clinicians must carefully balance effective dosing against the risk of toxicity, including…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.